20 articles
Novel KH-1 supplement containing spermidine and probiotics tested for autophagy stimulation and glucose control in 42 prediabetic participants.
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Cassava Sciences' 76-week Phase 3 trial of simufilam for Alzheimer's was terminated, raising questions about the drug's future.
Vanderbilt study tests whether reducing calcium-to-magnesium ratios through targeted supplementation can improve brain function in seniors.
UNC study reveals choline requirements vary dramatically between individuals based on hormone levels and genetic makeup.
A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.
Akeso's AK102 faces a placebo-controlled test in high-cardiovascular-risk patients already on statins and ezetimibe.
Amgen's siRNA therapy olpasiran targets lipoprotein(a), a stubborn cardiovascular risk factor with no approved treatments.
Small trial tests whether dasatinib plus quercetin can improve brain blood flow and cognition in at-risk older adults.
Clinical trial tests whether senolytic compounds can reduce cellular aging burden and improve bone health markers in older adults.
A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.
Cornell study tests whether N-acetylcysteine can restore protective antioxidants in Parkinson's patients' brains using advanced brain imaging.
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
A Phase 3 trial examines whether bococizumab slashes LDL in statin-treated patients at elevated cardiovascular risk.
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.
Study investigates why cholesterol-regulating protein PCSK9 responds differently to hormones in men versus women.
12-week trial tests supplement combination for improving lipid metabolism and appetite control in overweight middle-aged adults.
Oxford researchers tested whether spermidine could rejuvenate aging immune systems and improve vaccination effectiveness in adults over 65.
New research reveals how one intense workout session rapidly alters sphingolipids, key molecules that regulate aging and cellular health.
